Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

• Status: Completed
• Trial end date: 2020-03-12
• Target enrollment: 0
• Participant gender: All

Summary

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• - Age group 20-60 years

• ASA grade 1 and 2

• control hypertensive patients.

Exclusion Criteria:

• - Consent not given

• ASA Grade 3 and 4

• history of myocardial ischemia or infarction, or had an abnormal ECG on admission to the hospital

• Patients with cardiovascular, pulmonary, hepatic, and renal disease.

• Patients on B blockers.

• patients with difficult airway; laryngoscopy and intubation time more than 20 s, or requiring more than two attempts will be exclude from the study.